Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells
The zinc complex of 3,5-di-tert-butyl salicylate (Zn{[CH 3 ) 3 C] 2 Sal} 2 2− ) is a zinc ion chelate of salicylate. In this study, we found that this compound inhibits viability, invasion, and migration and induces apoptosis in triple-negative breast cancer 4T1 cells. RNA-seq showed that the expres...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2022-03, Vol.12 (1), p.4545-4545, Article 4545 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The zinc complex of 3,5-di-tert-butyl salicylate (Zn{[CH
3
)
3
C]
2
Sal}
2
2−
) is a zinc ion chelate of salicylate. In this study, we found that this compound inhibits viability, invasion, and migration and induces apoptosis in triple-negative breast cancer 4T1 cells. RNA-seq showed that the expression of 17 genes was upregulated and 26 genes were downregulated significantly by Zn{[CH
3
)
3
C]
2
Sal}
2
2−
treatment. Further GO and KEGG analysis showed that the activity of Zn{[CH
3
)
3
C]
2
Sal}
2
2−
against triple-negative breast cancer cells may be involved in the JAK-STAT3, HIF-1, and TNF signaling pathways. The expression of key genes was verified by RT–PCR. The phosphorylation of STAT3 and its upstream SRC decreased drastically upon Zn{[CH
3
)
3
C]
2
Sal}
2
2−
treatment, as demonstrated by western blot. Our results indicate that Zn{[CH
3
)
3
C]
2
Sal}
2
2−
inhibits the activity of TNBC cells by downregulating the STAT3 signaling through the SRC pathway. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-022-08704-0 |